Pfizer, BioNTech to delay seeking authorization of their COVID-19 shot in young childrenMarket Watch • 02/11/22
Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of AgeBusiness Wire • 02/11/22
Earnings Results: Pfizer expects a record $100 billion in revenue this year, thanks to COVID vaccines and treatmentsMarket Watch • 02/08/22
Pfizer Inc. (PFE) CEO Albert Bourla on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/08/22
Pfizer CEO says chances are 'very high' FDA will approve low-dose Covid shots for kids under 5CNBC • 02/08/22
Pfizer Triggers $28 Billion Stock Plunge After Warning Covid Vaccine Sales May Disappoint This YearForbes • 02/08/22
Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with itBusiness Insider • 02/08/22